Citigroup just slapped a Sell rating on one of 2026's most explosive biotech stocks, warning that soaring investor hopes around a cancer vaccine partnership with Merck have carried the valuation into dangerous territory.
We rated three quantum computing stocks a year ago, and the market handed back a brutal verdict on nearly all of them. Now the landscape has shifted enough that at least one of those…
SoFi just posted record loan originations and raised its full-year guidance, yet the stock sits nearly 40% in the red for the year. Something about that disconnect deserves a closer look.
Most families scrambling through the paperwork after a spouse dies never realize a frozen property tax bill can survive the death, and the qualifying age for the widow or widower may be decades younger…
Michael Burry just swapped unlimited-horizon short positions for expiring put contracts on Micron, accepting a hard deadline to be right before a stock up 550% in a year reports earnings in hours.
Cathie Wood just dumped one of this year's biggest AI winners to load up on a stock that has barely moved, and the reasoning behind that swap reveals a lot about where she thinks…
Palo Alto and CrowdStrike both reported blockbuster quarters and both credit AI for pushing cybersecurity to the top of every CIO's budget. But their strategies, valuations, and risk profiles point in opposite directions, and…
Five entry points into Micron stock, separated by decades, produced returns that diverge so wildly they challenge every assumption about patience rewarding long-term investors. The date you bought matters far more than you think.
Costco just posted its fifth consecutive earnings beat and carries a renewal rate that almost no retailer can match, yet the stock sits well off its highs. Our model reveals whether that gap is…